Infliximab Induced Sarcoidosis-Like Reaction

Authors

R. Andika, Rochester Regional HealthFollow
A. Salama, Rochester Regional HealthFollow
J. Stalica, Rochester Regional HealthFollow

Department

Medicine

Document Type

Conference Proceeding

Publication Title

American Journal of Respiratory and Critical Care Medicine

Conference Name

ATS 2020 International Conference

Conference Date

2020

Abstract

Introduction: Infliximab is a chimeric anti-tumor necrosis alpha (TNF-α) monoclonal antibody that induces inflammatory cell lysis. Sarcoidosis-like reaction in patients treated with anti-TNF-α agents is uncommon.

First Page

A3123

DOI

10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A3123

Publication Date

1-1-2020

Publisher

American Thoracic Society

Comments

Thematic Poster Sessions. B36. Case Reports In Biologic And Chemotherapeutic Agent Induced Lung Disease

Recommended Citation

Andika, R., Salama, A., & Stalica, J. (2020). Infliximab Induced Sarcoidosis-Like Reaction. American Journal of Respiratory and Critical Care Medicine, A3123. https://doi.org/10.1164/ajrccm-conference.2020.201.1_MeetingAbstracts.A3123